Application 050285
- Type
- NDA
- Sponsor
- PHARMACIA AND UPJOHN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MYCIFRADIN | NEOMYCIN SULFATE | SOLUTION;ORAL | EQ 87.5MG BASE/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050285-001 | MYCIFRADIN | NEOMYCIN SULFATE | EQ 87.5MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | N050285-001 | MYCIFRADIN | EQ 87.5MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N050285-001 | MYCIFRADIN | EQ 87.5MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N050285-001 | MYCIFRADIN | EQ 87.5MG BASE/5ML | SOLUTION / ORAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neomycin Sulfate | NEOMYCIN SULFATE | Shaanxi Shuvita Biotech Co., Ltd | 573e1fe7-4d9d-0a5f-e063-6394a90a85a8 | 2026-07-22 | Warnings | NEOMYCIN SULFATE |
| Neomycin Sulfate | NEOMYCIN SULFATE | REMEDYREPACK INC. | 461f62b9-b9ec-43f2-aee7-0895638105b8 | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | NEOMYCIN SULFATE |
| Neomycin Sulfate | NEOMYCIN SULFATE | Chartwell RX, LLC | 0aa6947b-4739-4b00-be93-7303a5fc687d | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | NEOMYCIN SULFATE |
| Neomycin Sulfate | NEOMYCIN SULFATE | Aldermed Inc. | 4978bb06-8b7c-9a44-e063-6294a90ac4cf | 2026-02-12 | Warnings | NEOMYCIN SULFATE |
| VITACILINA NEOMYCIN SULFATE FIRST AID ANTIBIOTIC | NEOMYCIN SULFATE | Compania Internacional de Comercio, S.A.P.I de C.V. | ba7a3331-466e-496f-bebd-9ee7067bcdb2 | 2025-11-19 | Warnings | NEOMYCIN SULFATE |
| POMADA SULFA FIRST AID ANTIBIOTIC | NEOMYCIN SULFATE | GRANDALL DISTRIBUTING, LLC | 1d8e1fca-6864-7c08-e063-6394a90a08b6 | 2025-10-28 | Warnings | NEOMYCIN SULFATE |
| Antibiotic | NEOMYCIN SULFATE | Total Resources International | 0725364b-b243-4891-af2f-a6049366d038 | 2025-10-10 | Warnings | NEOMYCIN SULFATE |
| Neomycin Sulfate | NEOMYCIN SULFATE | Solaris Pharma Corporation | f430c5d9-ae82-3314-e053-2a95a90af04c | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | NEOMYCIN SULFATE |
| Pomada de Sulfa | NEOMYCIN SULFATE | Menper Distributors, Inc. | 216f4d22-e5e8-46c8-a4ef-8d1532792b56 | 2025-07-22 | Warnings | NEOMYCIN SULFATE |
| First Aid Only Neomycin Antibiotic | NEOMYCIN SULFATE | Acme United Corporation | c651e98e-aabe-de46-e053-2a95a90a6307 | 2024-11-19 | Warnings | NEOMYCIN SULFATE |
| Single Antibiotic with Neomycin | NEOMYCIN SULFATE | Safetec of America | e989cf7e-f3d1-42d2-af45-fc80095b97cb | 2024-02-08 | Warnings | NEOMYCIN SULFATE |
| Neomycin Sulfate | NEOMYCIN SULFATE | Teva Pharmaceuticals USA, Inc. | 777dbfab-f83e-4738-ae1e-78619a9f82a7 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | NEOMYCIN SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.